Clinical trial
Alzheimer's Disease Neuroimaging Initiative 3
NCT02854033
Study timeline
Study start (actual)2016-12-02Date precision: day
Registry last updated2026-03-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Mild Cognitive Impairment (MCI)unresolved
Alzheimer's Disease (AD)unresolved
Interventions
Sponsors & collaborators
University of Southern Californialead sponsor
National Institute on Aging (NIA)collaborator
Alzheimer's Therapeutic Research Institutecollaborator
Mapped research locations
New YorkNew York, United States3HoustonTexas, United States2BostonMassachusetts, United States2ChicagoIllinois, United States2Los AngelesCalifornia, United States2Washington D.C.District of Columbia, United States2PhoenixArizona, United States2ProvidenceRhode Island, United States2LondonOntario, Canada2PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02854033 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.